India Globalization Capital IncAdd to My Watchlist

IGC:USNYSEAmericanIndustry: Medical-Biomedical/Gene
  • 0.38
    Last
  • 0.01  -2.21%
    Today's Change
  • 0.39
    Previous Close
  • Today
     
    0.19
    0.80
    52 Week Low - High
8:04 pm ET 9/22/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding27 million
Market Cap$10 million
Return on Equity ttm-19.95%
Last DividendIGC:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.076
EPS: Year Est. -- ttm--
 
EPS: Quarterly Actual -- -0.02
EPS: Quarterly Est. -- --
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate58.82
Company Description
India Globalization Capital, Inc. (IGC) operates as a biopharmaceutical company. The Company develops proprietary cannabinoid based biopharmaceutical therapies for end of life supportive care, hospice care, and chronic neurological and oncological diagnosis. IGC serves the healthcare sector in the United States.
Revenue$580,372
Net Income$-2 million
Total Assets$11 million
Employees31
Web Siteww.igcinc.us

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!